• SIGN IN
  • GET HELP
  •  

    Home Study Details


    Program Type

    Home Study Webcast

    Credits

    1 Contact Hour(s)

    Release Date

    Saturday, December 15, 2018

    Offline Date

    Sunday, December 15, 2019

    ACPE Expiration Date

    Friday, November 5, 2021

    Target Audience

    Pharmacist, Nurse

    Cost

    $0.00

    • Overview

      Breast cancer occurs in about 10 - 15% of women in the United States. While the overall breast cancer death rate has dropped significantly, early detection and treatment certainly offers greater chances for survival. Advances in medical technology offer more effective treatment options. Genomic testing assists in individualizing treatment and helps determine whether chemotherapy is appropriate therapy to prevent recurrence. While pharmacists and pharmacies certainly have a role in screening and early detection, pharmacists should also understand the role of genomic testing in individualizing treatment of early stage breast cancer after surgery to remove tumors. 

      Handouts

      • Slide Document :   18203H01_6pp.pdf
      • Slide Document :   18203H01_2pp.pdf

      Financial Support By

      Genomic Health, Inc.
    • Pharmacist

      Describe the use and incorporation of the Breast Recurrence Score test as the recognized standard of care in breast cancer treatment guidelines to individualize treatment decisions after tumor removal
      Identify strategies to explain to patients the clinical value of genomic testing in individualizing adjuvant therapy in early stage breast cancer after tumor removal
      Outline the recent study findings on genomics testing of tumors and considerations for adjuvant therapy

      Nurse

      Outline the recent study findings on genomics testing of tumors and considerations for adjuvant therapy
      Identify strategies to explain to patients the clinical value of genomic testing in individualizing adjuvant therapy in early stage breast cancer after tumor removal
      Describe the use and incorporation of the Breast Recurrence Score test as the recognized standard of care in breast cancer treatment guidelines to individualize treatment decisions after tumor removal
    • Activity Type

      Knowledge

      CE Broker

      20-657447

      Universal Activity Number

      Pharmacist 0798-0000-18-203-H01-P
      Nurse 0798-0000-18-203-H01-N

      ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

      PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

      In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.


    HARDWARE REQUIREMENTS
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
     


    SOFTWARE REQUIREMENTS
    Microsoft Edge
    Internet Explorer 8.0 or higher
    Google Chrome
    Safari
    Firefox 3.0.3 or higher


    NETWORK REQUIREMENTS
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
     
     

    This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).